Resources We partner with pharma to advance neuroscience research All ResourcesConferencesPress ReleasesIn the newsPublications Clinically Related Rare Neurodevelopmental Disorders Display Distinct Functional Phenotypes in Human Featured at SfN 2024 October 5, 2024 | Conferences Read More → Modulation of Glial Differentiation in a 3D iPSC-derived CNS Model Featured at SfN 2024 October 5, 2024 | Conferences Read More → Onset of CIPN Delayed Through SARM1 Inhibition in Human NerveSim Preclinical Drug-Discovery Platform Featured at SfN 2024 October 5, 2024 | Conferences Read More → AxoSim Appoints Stuart Gibb as Vice President of Sales and Marketing to Drive Revenue Growth September 17, 2024 | Press Releases Read More → Assessment of a 3D neural spheroid model to detect pharmaceutical-induced neurotoxicity September 16, 2024 | Publications Read More → AxoSim Speaks at 2024 ADC Toxicity Summit July 25, 2024 | Conferences Read More → MPS Features Three AxoSim Scientists at 2024 World Summit June 25, 2024 | Conferences Read More → AxoSim Appoints Alif Saleh as Chief Executive Officer to Drive Market Adoption June 11, 2024 | Press Releases Read More → Comparative assessment of Ca2+ oscillations in 2- and 3-dimensional hiPSC derived and isolated cortical neuronal networks May 24, 2024 | Publications Read More → AxoSim Posters Featured at SOT 2024 Annual Meeting March 26, 2024 | Conferences Read More → AxoSim Appoints Two Biotech Industry Veterans as Co-Chairs of Its Board of Directors February 28, 2024 | Press Releases Read More → Fierce Biotech: Organoids touted as future of brain disorder R&D as AxoSim scoops up tech from Vyant subsidiary December 15, 2023 | In the news Read More → Latest Acquisition Lands AxoSim in the News November 28, 2023 | In the news Read More → AXOSIM EXTENDS LEADERSHIP IN HUMAN ORGANOIDS FOR NEUROLOGICAL DRUG DISCOVERY WITH ACQUISITION OF STEMONIX MICROBRAIN™ TECHNOLOGY October 31, 2023 | Press Releases Read More → AxoSim Enters Into a Definitive Agreement to Acquire Vyant Bio’s StemoniX Assets July 17, 2023 | Press Releases Read More → 1 2 3 Next »
